Delivery Order SPE2DB24D2205-SPE2DB24FDSKE
Award Date
4/9/24
Potential Completion Date
4/10/24
Potential Value
$40K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, with a ceiling value of $6,192.50 and a performance period through April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product BYDUREON BCISE 2 MG AUTOINJECT 0.85ML. The delivery order has a ceiling value of $1,831.88 and a performance period through April 11, 2024. This award is part of a larger indefinite delivery contract (IDC) held...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BYDUREON BCISE 2 MG AUTOINJECT 0.85ML pharmaceutical products. The order has a ceiling value of $15,286.44 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $7,727.44 firm fixed price delivery order contract for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of Bydureon BCISE 2 mg auto-injector, a pharmaceutical product. The contract has a ceiling value of $1,570.20 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4557044485 - BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a specialty pharmaceutical product. The award has a ceiling value of $16,259.59 and a period of performance through April 29, 2022. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,570.20 firm fixed price contract is for the supply of the pharmaceutical product Bydureon Bcise 2 mg autoinjector 0.85 mL. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product BYDUREON BCISE 2 MG AUTOINJECT 0.85ML. The contract has a ceiling value of $5,233.90 and an ultimate completion date of September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which allows the government to...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Bydureon BCISE 2 MG Autoject 0.85ML. The order has a ceiling value of $6,796.28 and an ultimate completion date of August 23, 2024. This contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, is delivering this product through an Indefinite Delivery Contract (IDC) valued up...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Bydureon BCise 2 mg autoinjector. The delivery order has a potential value of $6,615.12 and a completion date of May 5, 2022. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery...